SeaStar's QUELIMMUNE Can Cut Pediatric Sepsis Deaths In Half

benzinga.com/partner/biotech/25/06/46116092/seastars-quelimmune-can-cut-pediatric-sepsis-deaths-in-half

SeaStar Medical Holding Corp. (NASDAQ:ICU), the commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, has made a lot of inroads on that front with QUELIMMUNE. A humanitarian medical device,…

This story appeared on benzinga.com, 2025-06-26 13:56:01.
The Entire Business World on a Single Page. Free to Use →